Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
05 Dec 2024 |
PSC05 |
Change of details for Organon & Co., Inc. as a person with significant control on 3 June 2021
|
|
|
30 Sep 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
10 Jul 2024 |
CS01 |
Confirmation statement made on 10 July 2024 with updates
|
|
|
21 Jun 2024 |
AD01 |
Registered office address changed from Organon Pharma (Uk) Limited Shotton Lane Cramlington England and Wales NE23 3JU United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington NE23 3JU on 21 June 2024
|
|
|
06 Jun 2024 |
AD01 |
Registered office address changed from The Hewett Building 14 Hewett Street London EC2A 3NP United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington England and Wales NE23 3JU on 6 June 2024
|
|
|
25 Mar 2024 |
TM01 |
Termination of appointment of Simon Khalid Hussain as a director on 29 February 2024
|
|
|
25 Mar 2024 |
AP01 |
Appointment of Isabel Vandenberk as a director on 1 March 2024
|
|
|
22 Mar 2024 |
TM01 |
Termination of appointment of Torben Dahl as a director on 29 February 2024
|
|
|
22 Mar 2024 |
TM01 |
Termination of appointment of Simon Nicholson as a director on 15 February 2024
|
|
|
22 Mar 2024 |
AP01 |
Appointment of Ms Sandy Lindsey as a director on 1 March 2024
|
|
|
22 Mar 2024 |
AP01 |
Appointment of Mr Michael Whale as a director on 1 March 2024
|
|
|
21 Mar 2024 |
AP01 |
Appointment of Mr Josef Ralph Laskowski as a director on 1 March 2024
|
|
|
05 Oct 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
10 Jul 2023 |
CS01 |
Confirmation statement made on 10 July 2023 with no updates
|
|
|
13 Sep 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
13 Jul 2022 |
CS01 |
Confirmation statement made on 10 July 2022 with no updates
|
|
|
20 Dec 2021 |
RP04AP01 |
Second filing for the appointment of Torben Dahl as a director
|
|
|
20 Sep 2021 |
AP01 |
Appointment of Dahl Torben as a director on 28 May 2021
-
ANNOTATION
Clarification a second filed AP01 was registered 20/12/2021.
|
|
|
20 Sep 2021 |
AP01 |
Appointment of Simon Khalid Hussain as a director on 28 May 2021
|
|
|
02 Sep 2021 |
AA |
Full accounts made up to 31 December 2020
|
|
|
21 Jul 2021 |
CS01 |
Confirmation statement made on 10 July 2021 with updates
|
|
|
11 Jun 2021 |
PSC02 |
Notification of Organon & Co., Inc. as a person with significant control on 2 June 2021
|
|
|
11 Jun 2021 |
PSC07 |
Cessation of Merck & Co., Inc. as a person with significant control on 2 June 2021
|
|
|
11 Jun 2021 |
PSC02 |
Notification of Merck & Co., Inc. as a person with significant control on 22 March 2021
|
|
|
11 Jun 2021 |
PSC07 |
Cessation of Merck Sharp & Dohme (Uk) Limited as a person with significant control on 22 March 2021
|
|